Related references
Note: Only part of the references are listed.Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis
Rob W. Flynn et al.
RESPIRATORY RESEARCH (2014)
Comorbid Diabetes and COPD Impact of corticosteroid use on diabetes complications
Gillian E. Caughey et al.
DIABETES CARE (2013)
Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
Eric D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
J. F. Donohue et al.
RESPIRATORY MEDICINE (2013)
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
Donald P. Tashkin et al.
RESPIRATORY RESEARCH (2013)
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)
Christer Janson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
David Price et al.
PRIMARY CARE RESPIRATORY JOURNAL (2013)
Inhaled corticosteroids in severe COPD
Jean Bousquet
LANCET RESPIRATORY MEDICINE (2013)
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
Claus F. Vogelmeier et al.
LANCET RESPIRATORY MEDICINE (2013)
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
Mark T. Dransfield et al.
LANCET RESPIRATORY MEDICINE (2013)
Effect of Statins on Total Cholesterol Concentrations, Cardiovascular Morbidity, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
Xia Sheng et al.
CLINICAL THERAPEUTICS (2012)
Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
Amir Sharafkhaneh et al.
RESPIRATORY MEDICINE (2012)
How far is real life from COPD therapy guidelines? An Italian observational study
Antonio Corrado et al.
RESPIRATORY MEDICINE (2012)
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
Donald A. Mahler et al.
THORAX (2012)
Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
Thys van der Molen et al.
PRIMARY CARE RESPIRATORY JOURNAL (2012)
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
Dennis E. Doherty et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Identification of Biologic Clusters and Their Biomarkers
Mona Bafadhel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The Strange Case of Community-Acquired Pneumonia in COPD
Antoni Torres et al.
CHEST (2011)
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
A. Singanayagam et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: A meta-analysis
Jianmiao Wang et al.
RESPIROLOGY (2011)
Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies
Yoon K. Loke et al.
THORAX (2011)
Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
Philip M. Short et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology
Nighat J. Nadeem et al.
RESPIRATORY RESEARCH (2011)
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Samy Suissa et al.
AMERICAN JOURNAL OF MEDICINE (2010)
COPD Management in Primary Care: An Observational, Community Pharmacy-Based Study
Els Mehuys et al.
ANNALS OF PHARMACOTHERAPY (2010)
Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD Patients
Boudewijn Van de Maele et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2010)
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms
J. A. van Noord et al.
RESPIRATORY MEDICINE (2010)
The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
COPD routine management in France: Are guidelines used in clinical practice?
G. Jebrak
REVUE DES MALADIES RESPIRATOIRES (2010)
QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease
Jan A. van Noord et al.
THORAX (2010)
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease A Randomized Trial
Therese S. Lapperre et al.
ANNALS OF INTERNAL MEDICINE (2009)
Inhaled corticosteroids in COPD: a case in favour
D. S. Postma et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Inhaled corticosteroids in COPD: the case against
S. Suissa et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C. Crim et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study
Bartolome R. Celli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
Jadwiga A. Wedzicha et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
R. Siva et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
Peter Kardos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease
SD Singh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
P Calverley et al.
LANCET (2003)
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
PS Burge et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
